Concepedia

Wei‐Ming Su

WS

8

Publications

318

Citations

8

H-Index

2020

Active since

Affiliations

Sichuan University(Current)

West China Hospital of Sichuan University

Shanghai Center for Brain Science and Brain-Inspired Technology

West China Medical Center of Sichuan University

Chinese Academy of Sciences

Wei‐Ming Su is an author at Sichuan University specializing in tumor biology, lung cancer, and prognostic biomarkers.

ORCID

Top concepts

Publications per year

2020–2024

8

Publications

8

Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer’s disease

Wei‐Ming Su, Xiaojing Gu, Meng Dou et al. · Journal of Neurology Neurosurgery & Psychiatry · 2023 · 139 citations · Full text

TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitro

Qing‐Qing Duan, Han Wang, Wei‐Ming Su et al. · BMC Medicine · 2024 · 37 citations · Full text

Systematic druggable genome‐wide Mendelian randomization identifies therapeutic targets for sarcopenia

Kang‐Fu Yin, Ting Chen, Xiaojing Gu et al. · Journal of Cachexia Sarcopenia and Muscle · 2024 · 37 citations · Full text

Expanding causal genes for Parkinson’s disease via multi-omics analysis

Xiaojing Gu, Wei‐Ming Su, Meng Dou et al. · npj Parkinson s Disease · 2023 · 35 citations · Full text

The mutation spectrum of <scp>Parkinson‐disease</scp>‐related genes in early‐onset Parkinson's disease in ethnic Chinese

Yongping Chen, Shihui Yu, Guohui Zhang et al. · European Journal of Neurology · 2022 · 28 citations

Rows per page

1–5 of 8